Skip to content
healthcare.dev

ANTI AGE SKIN

NDC 17089-046, alpha-tocopherol - ascophyllum nodosum - botryoglossum platycarpum - fucus serratus - fucus vesiculosus - isoleucine - leucine - retinol - selenium - sus scrofa capillary tissue - sus scrofa collagen - sus scrofa placenta - sus scrofa skin - ubidecarenone - ulva lactuca extract - laminaria digitata, pellet, from Guna spa.

Product NDC
17089-046
Status
Listed
Labeler
Guna spa
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17089-046 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALPHA-TOCOPHEROL4 [hp_C]/4g
  • LAMINARIA DIGITATA4 [hp_C]/4g
  • BOTRYOGLOSSUM PLATYCARPUM4 [hp_C]/4g
  • FUCUS SERRATUS4 [hp_C]/4g
  • SUS SCROFA CAPILLARY TISSUE4 [hp_C]/4g
  • UBIDECARENONE4 [hp_C]/4g
  • SUS SCROFA COLLAGEN4 [hp_C]/4g
  • FUCUS VESICULOSUS4 [hp_C]/4g
  • ISOLEUCINE4 [hp_C]/4g
  • ASCOPHYLLUM NODOSUM4 [hp_C]/4g
  • LEUCINE4 [hp_C]/4g
  • SUS SCROFA PLACENTA4 [hp_C]/4g
  • RETINOL4 [hp_C]/4g
  • ULVA LACTUCA EXTRACT4 [hp_C]/4g
  • SELENIUM4 [hp_C]/4g
  • SUS SCROFA SKIN4 [hp_C]/4g

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Cells, Epidermal [EXT]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Animal Skin Allergenic Extract [EPC]

Package NDCNDC-11Package
17089-046-20170890046202 TUBE in 1 BOX (17089-046-20) / 4 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17089-046 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17089-046 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17089-046. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.